NextRNA Therapeutics is committed to discovering novel ncRNAs that cause disease through their proprietary target and drug discovery engine. By disrupting the disease-related ncRNA-protein interaction, the company's discovery platform enables medical practitioners to help cure a variety of diseases. The company's team is driven by a common passion for making an impact on science and patients, and they are currently advancing two small molecule therapeutic programs in oncology and immunology.